Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment

OBJECTIVE: To provide context for the malignancy experience in the rheumatoid arthritis (RA) abatacept clinical development programme (CDP) by performing comparisons with similar RA patients and the general population. METHODS: Malignancy outcomes included total malignancy (excluding non-melanoma sk...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, T A, Smitten, A L, Franklin, J, Askling, J, Lacaille, D, Wolfe, F, Hochberg, M C, Qi, K, Suissa, S
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2009
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770103/
https://www.ncbi.nlm.nih.gov/pubmed/19054822
http://dx.doi.org/10.1136/ard.2008.097527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770103/
https://www.ncbi.nlm.nih.gov/pubmed/19054822
http://dx.doi.org/10.1136/ard.2008.097527

Ejemplares similares